Sym015
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sym015, covering 2022-06-22 to 2022-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies [Phase 1, Phase 2]